… d prolonged use of this medication should be avoided.
Evidence suggests that metronidazole is carcinogenic in certain animal species. There is no evidence to date of a carcinogenic effect in human.
This product contains 50 mg of propylene glycol (E1520) in each gram which is equivalent to 5% w/w and may cause skin irritation. This product also contains hydroxybenzoic acid esters which may cause allergic reactions (possibly delayed) and bronopol which may cause local skin reactions (e.g. contact dermatitis).
… tains 500 mg of sucrose in each ml. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
This medicine contains 12.35 mg propylene glycol (E1520) in each ml.
• Co-administration with any substrate for alcohol dehydrogenase such as ethanol may induce adverse effects in children less than 5 years old.
• While propylene glycol has not been shown to cause …
… se and 125mg of sucrose in each ml. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
This medicine contains 31.1 mg propylene glycol (E1520) in each ml.
• Co-administration with any substrate for alcohol dehydrogenase such as ethanol may induce adverse effects in children less than 5 years old.
• While propylene glycol has not been shown to cause r …